Literature DB >> 32671534

Prevalence of Depression or Depressive Symptoms in Patients with Narcolepsy: a Systematic Review and Meta-Analysis.

Xiao Li1,2, Larry D Sanford3, Qiang Zong4, Ye Zhang1, Lu Tan1, Taomei Li1, Rong Ren1, Junying Zhou1, Fang Han5, Xiangdong Tang6.   

Abstract

A meta-analysis was conducted to review the prevalence and associated moderators of depression or depressive symptoms in patients with narcolepsy. An extensive search of the literature yielded 1104 articles and abstracts, of which 31 studies were included in the meta-analysis. Meta-analysis revealed that the overall pooled prevalence of depression or depressive symptoms in patients with narcolepsy was 32% (95% Confidence Interval, 28-36%) with high between-study heterogeneity (Q = 249.77, df = 30, p < 0.001, τ2 = 0.0087, I2 = 88%). An analysis of 13 studies with healthy control groups indicated that narcolepsy was associated with a significantly increased risk of depression or depressive symptoms (Odds Ratio 3.48, 95% Confidence Interval 2.73-4.45; Q = 41.23, df = 12, p < 0.001, τ2 = 0.0087, I2 = 70.9%). The prevalence of depression or depressive symptoms in patients with narcolepsy was significantly affected by study design (Q = 5.05, p = 0.02) and recruitment setting (Q = 5.98, p = 0.01), and was marginally affected by age group (Q = 3.44, p = 0.06). The results indicate that narcolepsy patients should be closely monitored for depression and depressive symptoms and that early screening should be considered. However, these conclusions should be tempered because of high variability between studies. The estimates across studies are very inconsistent, indicating the need for larger, multicenter studies, with stringent case definitions.

Entities:  

Keywords:  Depression; Meta-analysis; Narcolepsy; Prevalence

Year:  2020        PMID: 32671534     DOI: 10.1007/s11065-020-09443-7

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  24 in total

1.  Impaired health status, daily functioning, and work productivity in adults with excessive sleepiness.

Authors:  Bonnie Dean; Daniel Aguilar; Colin Shapiro; William C Orr; Joshua A Isserman; Brian Calimlim; Gregory A Rippon
Journal:  J Occup Environ Med       Date:  2010-02       Impact factor: 2.162

2.  The Humanistic and Economic Burden of Narcolepsy.

Authors:  Natalia M Flores; Kathleen F Villa; Jed Black; Ronald D Chervin; Edward A Witt
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

Review 3.  A systematic review of cognitive function and psychosocial well-being in school-age children with narcolepsy.

Authors:  Jane E Blackwell; Hetaf A Alammar; Anna R Weighall; Ian Kellar; Hannah M Nash
Journal:  Sleep Med Rev       Date:  2016-07-18       Impact factor: 11.609

4.  Orexin and psychiatric symptoms in suicide attempters.

Authors:  Lena Brundin; Asa Petersén; Maria Björkqvist; Lil Träskman-Bendz
Journal:  J Affect Disord       Date:  2006-12-04       Impact factor: 4.839

Review 5.  Developmental Demands of Cognitive Behavioral Therapy for Depression in Children and Adolescents: Cognitive, Social, and Emotional Processes.

Authors:  Judy Garber; Sarah A Frankel; Catherine G Herrington
Journal:  Annu Rev Clin Psychol       Date:  2016       Impact factor: 18.561

6.  Facial expression recognition and emotional regulation in narcolepsy with cataplexy.

Authors:  Sophie Bayard; Muriel Croisier Langenier; Yves Dauvilliers
Journal:  J Sleep Res       Date:  2012-12-10       Impact factor: 3.981

7.  Psychological health in central hypersomnias: the French Harmony study.

Authors:  Y Dauvilliers; J Paquereau; H Bastuji; X Drouot; J-S Weil; V Viot-Blanc
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-11       Impact factor: 10.154

8.  Comorbidities in a community sample of narcolepsy.

Authors:  Alexander Cohen; Jay Mandrekar; Erik K St Louis; Michael H Silber; Suresh Kotagal
Journal:  Sleep Med       Date:  2017-11-21       Impact factor: 3.492

9.  Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.

Authors:  Lena Brundin; Maria Björkqvist; Asa Petersén; Lil Träskman-Bendz
Journal:  Eur Neuropsychopharmacol       Date:  2007-03-07       Impact factor: 4.600

10.  Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc Analysis.

Authors:  Richard K Bogan; Jed Black; Todd Swick; Mortimer Mamelak; Ruzica Kovacevic-Ristanovic; Kathleen F Villa; Fannie Mori; Jacques Montplaisir
Journal:  Neurol Ther       Date:  2017-07-13
View more
  5 in total

1.  Prevalence, incidence, and health care utilization of patients with narcolepsy: a population-representative study.

Authors:  Ulf Kallweit; Georg Nilius; Daniel Trümper; Tobias Vogelmann; Tino Schubert
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

Review 2.  Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know.

Authors:  Lois E Krahn; Phyllis C Zee; Michael J Thorpy
Journal:  Adv Ther       Date:  2021-12-11       Impact factor: 3.845

Review 3.  Pediatric Narcolepsy-A Practical Review.

Authors:  I-Hang Chung; Wei-Chih Chin; Yu-Shu Huang; Chih-Huan Wang
Journal:  Children (Basel)       Date:  2022-06-29

4.  Factors Associated with Depression and Sub-Dimension Symptoms in Adolescent Narcolepsy.

Authors:  Yang Yang; Chenyang Li; Long Zhao; Jing Li; Fang Han; Fulong Xiao
Journal:  Nat Sci Sleep       Date:  2021-07-06

5.  Paeoniflorin ameliorates chronic stress-induced depression-like behavior in mice model by affecting ERK1/2 pathway.

Authors:  Meiling Tang; Min Chen; Qiang Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.